- Home
- BMY vs EPD Comparison
BMY vs EPD Comparison
Compare BMY & EPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMY | EPD |
|---|---|---|
| Founded | 1887 | 1968 |
| Country | United States | United States |
| Employees | 32500 | 7300 |
| Industry | Biotechnology: Pharmaceutical Preparations | Natural Gas Distribution |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.5B | 80.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BMY | EPD |
|---|---|---|
| Price | $56.93 | $37.27 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 14 |
| Target Price | ★ $61.73 | $38.50 |
| AVG Volume (30 Days) | ★ 9.6M | 2.9M |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | 4.38% | ★ 5.67% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2.34 |
| Revenue Next Year | N/A | $6.35 |
| P/E Ratio | $17.26 | ★ $13.59 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $42.52 | $30.01 |
| 52 Week High | $62.89 | $40.17 |
Technical Indicators
Market Signals| Indicator | BMY | EPD |
|---|---|---|
| Relative Strength Index (RSI) | 49.88 | 42.77 |
| Support Level | $56.84 | $36.63 |
| Resistance Level | $57.43 | $37.31 |
| Average True Range (ATR) | 1.40 | 0.65 |
| MACD | 0.07 | -0.11 |
| Stochastic Oscillator | 48.12 | 20.19 |
Price Performance
Historical ComparisonAbout BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About EPD Enterprise Products Partners L.P.
Enterprise Products Partners is a master limited partnership that transports and processes natural gas, natural gas liquids, crude oil, refined products, and petrochemicals. It is one of the largest midstream companies, with operations servicing most producing regions in the continental US. Enterprise is particularly dominant in the NGL market and is one of the few MLPs that provide midstream services across the full hydrocarbon value chain.